Boai Nky Medical Holdings Ltd.

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

BOAI NKY MEDICAL HOLDINGS LTD.

21 YRS

Henan, China

CNY 343.6 Million

138528 m²

500-1000 people

Main Products: Polyvinylpyrrolidone(Pvp) / N-Vinyl-2-Pyrrolidone / Poly(Methyl Vinyl Ether-Alt-Maleic Anhydride) / 1-Ethenylazepan-2-one;1-Ethenylpyrrolidin-2-one / N-Vinylpyrrolidone/N-Vinylimidazole Copolymer(VP/VI) / Vinylimidazole / Methyl Vinyl Ether / N-Vinyl-2-Pyrrolidone

Henan, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

VERIFIEDMANUFACTURINGCOMPANY

Business Type

CRO

Total Employees

500-1000 People

Plant Size

208 Acres

Total Annual Revenue

CNY 992.1 Million

Production Experience

21+ Years

MAIN
PRODUCTS

1/3

Polyvinylpyrrolidone(Pvp)

CAS: 9003-39-8

Specification: PVP K30；K value: 27-32.4

Packing: 25 KG/Fibre Drum

Lead Time: In Stock

Inquiry

1/3

N-Vinyl-2-Pyrrolidone

CAS: 88-12-0

Packing: 200 KG/Iron Drum

Lead Time: 14-30 days

Inquiry

1/3

OraRez AN

CAS: 9011-16-9

Specification: 98%

Packing: 25 KG/Fibre Drum

Lead Time: 14-30 days

Inquiry

ABOUT US

BOAI NKY MEDICAL HOLDINGS LTD.

Boai NKY medical Holdings Ltd. (NKY for short), stock code: 300109. The company's main business includes the production of polyvinylpyrrolidone (PVP) series products, vinyl methyl ether / maleic anhydride copolymer (PVM / MA, orezzi) and oral care products; Medical technology services such as early tumor screening, molecular diagnosis and individualized precision medicine with gene sequencing as the main technical platform. At present, the subsidiaries of xinkaiyuan include Boai xinkaiyuan (Beijing) Medical Technology Development Co., Ltd., Tianjin Boai xinkaiyuan International Trade Co., Ltd., Tianjin yarizi Pharmaceutical Technology Co., Ltd., Boai xinkaiyuan pharmaceutical and Chemical Equipment Co., Ltd., Wuhan hor Medical Technology Development Co., Ltd., Changsha Sanji Biotechnology Co., Ltd. and crystal Biotechnology (Shanghai) Ltd., overseas subsidiary: Germany Boai NKY Chemical Co., Ltd., overseas joint venture: Japan contract xinkaiyuan Pharmaceutical Co., Ltd. In April 2013, a new modern plant covering 208 mu (138800m2) with a total construction area of 50000m2 was completed, enabling the integrated production process of PVP and PVM / MA functional polymer product series. The main units include 12000 T / a GBL unit, 6000 T / a 2-pyrrolidone unit, 6000 T / a NVP unit, 2500 t / a PVM / MA COPOLYMER unit 2000 t / a vinyl ether unit and 10000 t / a PvP polymer unit. The current product series include: GBL, 2-pyrrolidone, NVP monomer, PVP K series (povidone), copolyvinone, PVPP (crosslinked povidone), PVP-I complex (povidone iodine), vinyl ether intermediate and PVM / MA copolymer. Xinkaiyuan is also the first domestic enterprise capable of producing PVP K12 (powder and liquid), PVP K90 (povidone K90) powder, PVP K60 powder, k120 powder, PVM / MA copolymer and high-purity vinyl ether intermediates.